Regulating the regulators: MicroRNA and Asthma

World Allergy Organization Journal

Volumn 4, Issue 6, 2011, Pages 94-103

  Wang, Jia Wang ^a,b   Li, Kunyu ^a,b   Hellermann, Gary ^a,b   Lockey, Richard F ^b,d   Mohapatra, Subhra ^a,c,d   Mohapatra, Shyam ^a,b,d  

^a Nanomedicine Research Center   (United States)

^b Division of Allergy and Immunology   (United States)

^c Department of Molecular Medicine3 ^*  (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Asthma; Biomarkers; Circulating; Epigenetics; MicroRNA

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; ALLERGEN; ANTAGOMIR; CORTICOSTEROID; MICRORNA 146A; MICRORNA 146B; MICRORNA 150; MICRORNA 155; MICRORNA 181A; MICRORNA 223; MICRORNA 26A; MICRORNA 29B; MICRORNA 29C; MICRORNA 483; MICRORNA 574 5P; MICRORNA 672; MICRORNA 690; UNCLASSIFIED DRUG;

ASTHMA; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; IMMUNE SYSTEM; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; ALLERGIC ASTHMA; CHROMATIN; DNA METHYLATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG TARGETING; GENE EXPRESSION REGULATION; HISTONE MODIFICATION; IMMUNOTHERAPY; LIVER CANCER; NONHUMAN; RESPIRATORY TRACT INFLAMMATION; TH2 CELL;

EID: 85010976707     PISSN: 19394551     EISSN: None     Source Type: Journal    
DOI: 10.1186/1939-4551-4-6-94     Document Type: Review

References (125)

1. Tarlo SM, Malo JL. An ATS/ERS report: 100 key questions and needs in occupational asthma. Eur Respir J. 2006;27:607-614. (Pubitemid 43372537)
2. Maestrelli P, Boschetto P, Fabbri LM, Mapp CE. Mechanisms of occupational asthma. J Allergy Clin Immunol. 2009;123:531-542; quiz 543-544.
3. Schwartz DA. Etiology and pathogenesis of airway disease in children and adults from rural communities. Environ Health Perspect. (107) Suppl. 1999;3:393-401. (Pubitemid 29346985)
4. Moorman JE, Zahran H, Truman BI, Molla MT. Current Asthma Prevalence-United States, 2006-2008. Morbidity and Mortality Weekly Report (MMWR). 2011;60:84-86.
5. Mohapatra S. Potential of recombinant allergens as immunotherapeutic agents for allergy and asthma. In: Bousquet J, Yssel H, eds. Immunotherapy in Asthma. Philadelphia: Taylor & Francis; 1999;297-312.
6. Landrigan PJ, Schechter CB, Lipton JM, Fahs MC, Schwartz J. Environmental pollutants and disease in American children: estimates of morbidity, mortality, and costs for lead poisoning, asthma, cancer, and developmental disabilities. Environ Health Perspect. 2002;110:721-728.
7. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell. 2005;122:6-7. (Pubitemid 40977933)
8. Cullen BR. Transcription and processing of human microRNA precursors. Mol Cell. 2004;16:861-865. (Pubitemid 40018397)
9. Lee Y, Ahn C, Han J, Choi H, Kim J et al. The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003;425:415-419. (Pubitemid 37187272)
10. Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009;136:642-655.
11. Murchison EP, Hannon GJ. miRNAs on the move: miRNA biogenesis and the RNAi machinery. Curr Opin Cell Biol. 2004;16:223-229. (Pubitemid 38610401)
12. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet. 2005;37:766-770. (Pubitemid 41754896)
13. Seitz H, Royo H, Bortolin ML, Lin SP, Ferguson-Smith AC, Cavaille J. A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res. 2004;14:1741-1748. (Pubitemid 39276432)
14. Hakonarson H, Bjornsdottir US, Halapi E, Palsson S, Adalsteinsdottir, E et al. A major susceptibility gene for asthma maps to chromosome 14q24. Am J Hum Genet. 2002;71:483-491. (Pubitemid 34970120)
15. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006;34:D140-D144.
16. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell. 2005;120(1):21-24. (Pubitemid 40094599)
17. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell. 2007;27(1):91-105. (Pubitemid 46991392)
18. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19: 92-105.
19. Asirvatham AJ, Gregorie CJ, Hu Z, Magner WJ, Tomasi TB. Mi-croRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components. Mol Immunol. 2008;45:1995-2006. (Pubitemid 351226272)
20. Shalgi R, Pilpel Y, Oren M. Repression of transposable-elements-a microRNA anti-cancer defense mechanism? Trends Genet. 2010;26: 253-259.
21. Suzuki K, Kelleher AD. Transcriptional regulation by promoter targeted RNAs. Curr Top Med Chem. 2009;9:1079-1087 (2009).
22. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science. 2007;318:1931-1934.
23. Niepmann M. Activation of hepatitis C virus translation by a liver-specific microRNA. Cell Cycle. 2009;8:1473-1477.
24. Ma F, Liu X, Li D, Wang P, Li N, Lu L, Cao X. MicroRNA-466l upregulates IL-10 expression in TLR-triggered macrophages by antagonizing RNA-binding protein tristetraprolin-mediated IL-10 mRNA degradation. J Immunol. 2010;184(11):6053-6059.
25. Steitz JA, Vasudevan S. miRNPs: versatile regulators of gene expression in vertebrate cells. Biochem Soc Trans. 2009;37(Pt 5):931-935.
26. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, et al. Dicer is essential for mouse development. Naturegenetics. 2003;35(3): 215-217. (Pubitemid 37363172)
27. Zhou X, Jeker LT, Fife BT, Zhu S, Anderson MS, McManus MT, Bluestone JA. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med. 2008;205(9):1983-1991.
28. Cobb BS, Hertweck A, Smith J, O'Connor E, Graf D, et al. A role for Dicer in immune regulation. Journal of Experimental Medicine. 2006; 203(11):2519-2527. (Pubitemid 44664621)
29. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 2007;39(5):673-677. (Pubitemid 46676103)
30. Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 2010; 10(6):389-402.
31. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature. 2008;455(7209):64-71.
32. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature. 2008;455(7209):58-63.
33. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, et al. Regulation of the germinal center response by microRNA-155. Science. 2007; 316(5824):604-608. (Pubitemid 46683147)
34. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, et al. Requirement of bic/microRNA-155 for normal immune function. Science. 2007;316(5824):608-611. (Pubitemid 46683148)
35. Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N, Croce CM. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci USA. 2006;103(18):7024-7029.
36. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-depen-dent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA. 2006;103(33):12481-12486. (Pubitemid 44267285)
37. Perry MM, Moschos SA, Williams AE, Shepherd NJ, Larner-Svensson HM, Lindsay MA. Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. J Immunol. 2008;180(8):5689-5698.
38. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell. 2007;131(1):146-159. (Pubitemid 47498525)
39. Pykalainen M, Kinos R, Valkonen S, Rydman P, Kilpelainen M, et al. Association analysis of common variants of STAT6, GATA3, and STAT4 to asthma and high serum IgE phenotypes. The Journal of allergy and clinical immunology. 2005;115(1):80-87. (Pubitemid 40075425)
40. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, et al. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One. 2009;4(10):e7405.
41. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. MicroRNAs: new regulators of immune cell development and function. Nat Immunol. 2008;9(8):839-845. (Pubitemid 352038302)
42. Zhao Y, Srivastava D. A developmental view of microRNA function. Trends in biochemical sciences. 2007;32(4):189-197. (Pubitemid 46603281)
43. Holt PG, Macaubas C, Stumbles PA, Sly PD. The role of allergy in the development of asthma. Nature. 1999;402(6760 Suppl):B12-17.
44. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD. Interleukin-13: central mediator of allergic asthma. Science. 1998;282(5397):2258-2261. (Pubitemid 29004074)
45. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 1998;282(5397):2261-2263. (Pubitemid 29004075)
46. Los H, Postmus PE, Boomsma DI. Asthma genetics and intermediate phenotypes: a review from twin studies. Twin Res. 2001;4(2):81-93. (Pubitemid 32521722)
47. Balaci L, Spada MC, Olla N, Sole G, Loddo L, et al. IRAK-M Is Involved in the Pathogenesis of Early-Onset Persistent Asthma. Am J Hum Genet. 2007;80(6):1103-1114. (Pubitemid 47579346)
48. Hoffjan S, Nicolae D, Ober C. Association studies for asthma and atopic diseases: a comprehensive review of the literature. Respir Res. 2003;4:14.
49. Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Gwynn C, Redd SC. Surveillance for asthma-United States, 1980-1999. MMWR Sur-veill Summ. 2002;51(1):1-13.
50. Ho SM. Environmental epigenetics of asthma: an update. J Allergy Clin Immunol. 2010;126:453-465.
51. Yeatts K, Sly P, Shore S, Weiss S, Martinez F, et al. A brief targeted review of susceptibility factors, environmental exposures, asthma incidence, and recommendations for future asthma incidence research. Environ Health Perspect. 2006;114:634-640.
52. Kucharski R, Maleszka J, Foret S, Maleszka R. Nutritional control of reproductive status in honeybees via DNA methylation. Science. 2008; 319:1827-1830. (Pubitemid 351451590)
53. Miller RL, Ho SM. Environmental epigenetics and asthma: current concepts and call for studies. Am J Respir Crit Care Med. 2008;177: 567-573. (Pubitemid 351442162)
54. Barnes PJ. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009;6: 693-696.
55. Bowman RV, Wright CM, Davidson MR, Francis SM, Yang IA, Fong KM. Epigenomic targets for the treatment of respiratory disease. Expert Opin Ther Targets. 2009;13(6):625-640.
56. Kumar RK, Hitchins MP, Foster PS. Epigenetic changes in childhood asthma. Dis Model Mech. 2009;2(11-12):549-553.
57. Davalos V, Esteller M. MicroRNAs and cancer epigenetics: a macro-revolution. Curr Opin Oncol. 2009;22(1):35-45.
58. Sly PD, Boner AL, Bjorksten B, Bush A, Custovic A, et al. Early identification of atopy in the prediction of persistent asthma in children. Lancet. 2008;372(9643):1100-1106.
59. Mohapatra SS, Boyapalle S. Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma. Clin Microbiol Rev. 2008;21(3):495-504.
60. Artem S. Rogovskyy RAT, Stephen Mark Tompkins , and Les P. Jones. Virally Encoded MicroRNA (miRNA) Candidates for Gene Silencing. In: Lidbury BA MS, ed. Gene Profiles in Drug Design. Vol: CRC Press; 2009:11-28.
61. Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-depen-dent T helper cell type 2 responses to inhaled antigen. J Exp Med. 2002;196(12):1645-1651. (Pubitemid 36026476)
62. Eisenbarth SC, Cassel S, Bottomly K. Understanding asthma patho-genesis: linking innate and adaptive immunity. Curr Opin Pediatr. 2004;16(6):659-666. (Pubitemid 39552216)
63. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol. 2001;1(2):135-145. (Pubitemid 33741967)
64. Mattes J, Collison A, Plank M, Phipps S, Foster PS. Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc Natl Acad SciUSA. 2009;106(44):18704-18709.
65. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol. 2009;11(2):141-147.
66. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad SciUSA. 2007;104(5):1604-1609. (Pubitemid 46214637)
67. Lindsay MA. microRNAs and the immune response. Trends Immunol. 2008;29(7):343-351.
68. Mattes J, Yang M, Foster PS. Regulation of microRNA by antagomirs: a new class of pharmacological antagonists for the specific regulation of gene function? Am J Respir Cell Mol Biol. 2007;36(1):8-12. (Pubitemid 46067702)
69. Mattes J, Collison A, Foster PS. Emerging role of microRNAs in disease pathogenesis and strategies for therapeutic modulation. Curr Opin Mol Ther. 2008;10(2):150-157. (Pubitemid 351498877)
70. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. CurrBiol. 2002;12(9):735-739. (Pubitemid 34455427)
71. Wienholds E, Kloosterman WP, Miska E, Alvarez-Saavedra E, Ber-ezikov E, et al. MicroRNA expression in zebrafish embryonic development. Science. 2005;309(5732):310-311. (Pubitemid 40967869)
72. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings of the National Academy of Sciences of the United States of America. 2006;103(7):2257-2261. (Pubitemid 43271657)
73. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. 2007;67(6):2456-2468. (Pubitemid 46548930)
74. Shi M, Guo N. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer. Cancer Treat Rev. 2009;35(4):328-334.
75. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med. 2005;353(17):1793-1801. (Pubitemid 41549891)
76. Wang T, Zhang X, Obijuru L, Laser J, Aris V, et al. A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. Genes Chromosomes Cancer. 2007;46(4): 336-347. (Pubitemid 46411325)
77. Ahmed FE. Role of miRNA in carcinogenesis and biomarker selection: a methodological view. Expert Rev Mol Diagn. 2007;7:569-603. (Pubitemid 47547724)
78. Habbe N, Koorstra JB, Mendell JT, Offerhaus GJ, Ryu JK, et al. MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther. 2009;8:340-346.
79. Rane S, Sayed D, Abdellatif M. MicroRNA with a MacroFunction. Cell Cycle. 2007;6:1850-1855. (Pubitemid 47327902)
80. Jain KK. Cancer biomarkers: current issues and future directions. Curr Opin Mol Ther. 2007;9:563-571. (Pubitemid 350179096)
81. Wang Y, Liang Y, Lu Q. MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases. Clin Genet. 2008;74:307-315.
82. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008;110:13-21. (Pubitemid 351853251)
83. Mattie MD, et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer. 2006;5:24.
84. Polikepahad S, Creighton CJ, Zhu H, Harris A, Coarfa C, et al. Differentially expressed microRNAs in allergic asthma target genes underlying airway hyper-responsiveness and goblet cell hyperplasia. JImmunol. 2009;182:136.22.
85. Williams AE, et al. MicroRNA expression profiling in mild asthmatic human airways and effect of corticosteroid therapy. PLoS One. 2009; 4:e5889.
86. Lu TX, Munitz A, Rothenberg ME. MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol. 2009;182:4994-5002.
87. Garbacki N, et al. MicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets. PLoS One. 2011; 6:e16509.
88. Wang H, Ach RA, Curry B. Direct and sensitive miRNA profiling from low-input total RNA. RNA. 2007;13:151-159. (Pubitemid 46026189)
89. Wang JW, Cheng JQ. A simple method for profiling miRNA expression. Methods Mol Biol. 2008;414:183-190.
90. Shingara J, et al. An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA. 2005;11:1461-1470. (Pubitemid 41215448)
91. Nelson PT, et al. Microarray-based, high-throughput gene expression profiling of microRNAs. Nat Methods. 2004;1:155-161.
92. Vlassov VV, Laktionov PP, Rykova EY. Circulating Nucleic Acids as a Potential Source for Cancer Biomarkers. Current Molec Med. 2010; 10:142-165.
93. Hunter MP, Ismail N, Zhang XL, Aguda BD, Lee EJ, et al. Detection of microRNA Expression in Human Peripheral Blood Microvesicles. PLoS One. 2008;3(11):e3694.
94. Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer-a survey. Biochim Biophys Acta. 2007;1775(1):181-232. (Pubitemid 44911084)
95. Li Y, Jiang Z, Xu L, Yao H, Guo J, Ding X. Stability analysis of liver cancer-related microRNAs. Acta Biochim Biophys Sin (Shanghai). 2010;43(1):69-78.
96. Tsui NB, Ng EK, Lo YM. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem. 2002;48(10):1647-1653.
97. Hasselmann DO, Rappl G, Tilgen W, Reinhold U. Extracellular tyrosi-nase mRNA within apoptotic bodies is protected from degradation in human serum. Clin Chem. 2001;47(8):1488-1489. (Pubitemid 32678837)
98. Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artifacts no more. Trends Cell Biol. 2009;19(2):43-51.
99. Rechavi O, Erlich Y, Amram H, Flomenblit L, Karginov FV, et al. Cell contact-dependent acquisition of cellular and viral nonautonomously encoded small RNAs. Genes & Development. 2009;23(16):1971-1979.
100. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T. Secretory Mechanisms and Intercellular Transfer of Micro RNAs in Living Cells. Journal of Biological Chemistry. 2010;285(23):17442-17452.
101. . Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal. 2009;2(100):ra81.
102. . Zhang Y, Liu D, Chen X, Li J, Li L, et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. MolCell. 2010;39(1):133-144.
103. . Kosaka N, Izumi H, Sekine K, Ochiya T. microRNA as a new immune-regulatory agent in breast milk. Silence. 2010;1(1):7.
104. . Rechavi O, Erlich Y, Amram H, Flomenblit L, Karginov FV, et al. Cell contact-dependent acquisition of cellular and viral nonautonomously encoded small RNAs. Genes Dev. 2009;23(16):1971-1979.
105. . Wang K, Zhang SL, Marzolf B, Troisch P, Brightman A, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proceedings ofthe National Academy ofSciences ofthe United States of America. 2009;106(11):4402-4407.
106. . Wills-Karp M. Immunologic basis of antigen-induced airway hyperre-sponsiveness. Annu Rev Immunol. 1999;17:255-281. (Pubitemid 29241125)
107. . Bochner BS, Undem BJ, Lichtenstein LM. Immunological aspects of allergic asthma. Annu Rev Immunol. 1994;12:295-335. (Pubitemid 24140417)
108. . Joetham A, Takeda K, Taube C, Miyahara N, Matsubara S, et al. Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-beta. JImmunol. 2007;178(3):1433-1442. (Pubitemid 46154614)
109. . Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, et al. Relation of CD4+ CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet. 2004;363(9409):608- 615. (Pubitemid 38264178)
110. . Bjermer L, Diamant Z. Complementary therapy in asthma: inhaled corticosteroids and what? Curr Opin Pulm Med. 2009;15(1):46-51.
111. . Ivanova JI, Birnbaum HG, Hsieh M, Yu AP, Seal B, et al. Adherence to inhaled corticosteroid use and local adverse events in persistent asthma. Am JManag Care. 2008;14(12):801-809.
112. . Chapman KR. Safer inhaled corticosteroid therapy for asthma. Pediatrics. 2008;121(1):179-180.
113. . Lee SY, Kim JS, Lee JM, Kwon SS, Kim KH, et al. Inhaled cortico-steroid prevents the thickening of airway smooth muscle in murine model of chronic asthma. Pulm Pharmacol Ther. 2008;21(1):14-19.
114. . Loewenstein C, Mueller RS. A review of allergen-specific immunotherapy in human and veterinary medicine. Vet Dermatol. 2009;20:84-98.
115. . Pipet A, Botturi K, Pinot D, Vervloet D, Magnan A. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy. Respir Med. 2009;103:800-12.
116. . Niederberger V. Allergen-specific immunotherapy. Immunol Lett. 2009;122:131-133.
117. . Seguin RM, Ferrari N. Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease. Expert Opin Investig Drugs. 2009;18:1505-1517.
118. . Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med. 2006;100:1307-1317. (Pubitemid 43942329)
119. . Holgate ST. Novel targets of therapy in asthma. Curr Opin Pulm Med. 2009;15:63-71.
120. . Ballas ZK. Immunomodulators: a brave new world. J Allergy Clin Immunol. 2008;121:331-333. (Pubitemid 351215184)
121. . Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009;10:704-714.
122. . Kanellopoulou C, Monticelli S. A role for microRNAs in the development of the immune system and in the pathogenesis of cancer. Semin Cancer Biol. 2008;18:79-88.
123. . Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 2009;137(6):1005-1017.
124. . Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature. 2005;438(7068):685-689.
125. . Esquela-Kerscher A, Slack FJ. Oncomirs: microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259-269.